A Clinicopathologic Evaluation of Follicular Lymphoma Grade 3A Versus Grade 3B Reveals No Survival Differences

Archives of Pathology & Laboratory Medicine, Aug 2004 by Hsi, Eric D, Mirza, Imran, Lozanski, Gerard, Hill, John, Et al

16. Ott C, KatzenbergerT, Lohr A, etal. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002:99:3806-3812.

17. Rodriguez ), Mclaughlin P, Fayad L, et al. Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981. Ann Oncol. 2000:11:1551-1556.

18. Eshoa C, Perkins S, Kampalath B, Shidham V, juckett M, Chang CC. Decreased CDlO expression in grade III and in interfollicular infiltrates of follicular lymphomas. Am I Clin Pathol. 2001:115:862-867.

19. Lai R, Arber DA, Chang KL, Wilson CS, Weiss LM. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol. 1998:11:864-869.

20. Weisenburger DD, Gascoyne RD, Bierman PJ, et al. Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma. Leuk Lymphoma. 2000;36:513-523.

21. Yunis JJ, Frizzera C, Oken MM, McKenna J, Theologides A, Arnesen M. Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. N Engl J Med. 1987;316:79-84.

22. Offit K, Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RS. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer. 1991;3:189-201.

23. Bosga-Bouwer AC, van lmhoff CW, Boonstra R, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood. 2003:101:1149-1154.

24. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000:403:503-511.

25. Hans CP. A significant diffuse component predicts tor inferior survival in grade 3 follicular lymphoma, but cytologie subtypes do not predict survival. Blood. 2003;101:2363-2367.

Eric D. Hsi, MD; lmran Mirza, MD; Gerard Lozanski, MD; John Hill, MD; Brad Pohlman, MD; Matthew T. Karafa, PhD; Robert Coupland, MD

Accepted for publication April 15, 2004.

From the Departments of Clinical Pathology (Drs Hsi and Lozanski), Hematology and Medical Oncology (Drs Hill and Pohlman), and Biostatistics and Epidemiology (Dr Karat'a), Cleveland Clinic Foundation, Cleveland, Ohio; and the Department of Pathology, Cross Cancer Center, Edmonton, Alberta, Canada (Drs Mirza and Coupland).

Presented in abstract form at the annual meeting of the United States and Canadian International Academy of Pathology, Washington, DC, March 24, 2003.

The authors have no relevant financial interest in the products or companies described in this article.

Reprints: Eric D. Hsi, MD, Department of Clinical Pathology, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195 (e-mail: hsie@ccf.org).